< View All Healthcare Value Hub Articles

Pennsylvania Residents Worried about High Drug Costs–Support a Range of Government Solutions

State: Pennsylvania
Category: CHESS State Survey
Topic: Prescription Drugs

According to a survey of more than 1,150 Pennsylvania adults conducted from Oct. 30, 2020 to Dec. 10, 2020, residents are concerned about prescription drug costs and express a strong desire to enact solutions. 

  • 1 in 2 are worried about affording the cost of prescription drugs.
  • 1 in 5 did not fill a prescription, cut pills in half or skipped a dose of medicine in the past 12 months.
  • 28% of rural adults did not fill a prescription, cut pills in half or skipped a dose of medicine in the past 12 months compared to 17% of non-rural adults.
  • There is strong support among Pennsylvania adults for government action on drug costs regardless of political affiliation.

Many Pennsylvania residents experienced hardship in the prior 12 months due to the cost of prescription drugs. Indeed, cost concerns led 1 in 5 Pennsylvania adults (22%) to not fill a prescription, cut pills in half or skip a dose of medicine (see Figure 1).

DB 90 Figure 1.png

In addition, over half of all survey respondents (51%) reported being either “somewhat worried” or “very worried” about affording the cost of prescription drugs. Worry varied significantly by income group, with residents in households making less than $50,000 per year being almost twice as worried as those in households making more than $100,000 per year (see Figure 2). 

DB 90 Figure 2.png

There is significant regional variation with respect to drug affordability issues in Pennsylvania (see Table 1). Eighteen percent of adults in the South Central/Lehigh Valley, Southwest and Northeast/North Central regions had difficulty affording prescription drugs in the prior 12 months, while adults in the Northwest region fared much worse, with 33% struggling to afford prescription drugs. Surprisingly, most of the regional variation related to adults not filling their prescriptions. In contrast, similar numbers reported rationing prescription drugs, either by cutting pills in half or skipping doses, in each region. Residents of rural areas reported greater prescription drug affordability problems compared to adults in other areas of the state—28% of rural adults either did not fill a prescription, cut pills in half or skipped a dose of medicine in the past 12 months compared to 17% of non-rural Pennsylvania adults.

DB 90 Table 1.png

These hardships have a disproportionate impact on lower income households. As Figure 3 shows, households making less than $50,000 per year are more likely to have rationed their prescription medicines (by not filling a prescription, cutting pills in half or skipping a dose of medicine) than households with higher incomes. Still, roughly 1 in 5 households have experienced these hardships, regardless of the income group.

DB 90 Figure 3.png

When given more than 20 options, the option cited most frequently as being a “major reason” for high healthcare costs was “drug companies charging too much money:”

  • 70%—Drug companies charging too much money 
  • 65%—Insurance companies charging too much money 
  • 65%—Hospitals charging too much money 

When it comes to tackling high drug costs, respondents endorsed a number of strategies:

  • 92%—Authorize the Attorney General to take legal action to prevent price gouging or unfair prescription drug price hikes
  • 91%—Ensure the cost of widely needed vaccines are affordable for all
  • 89%—Require drug companies to provide advanced notice of price increases and information to justify those increases
  • 89%—Prohibit drug companies from charging more in the U.S. than abroad
  • 89%—Set standard prices for drugs to make them affordable 
  • 87%—Create a Prescription Drug Affordability Board to examine the evidence and establish acceptable costs for drugs

Pennsylvania residents are united in calling for the government to address high drug costs. Many have already tried taking personal action or would take action if given the opportunity:

  • 78% would switch from a brand name to a less expensive generic if given the option
  • 52% have tried to find out the cost of a drug beforehand

In light of these prescription drug cost concerns—as well as concerns about high healthcare costs generally—it is not surprising that Pennsylvania adults are extremely dissatisfied with the health system:

  • Just 34% agreed or strongly agreed that “we have a great healthcare system in the U.S.,
  • While 68% agreed or strongly agreed that “the system needs to change.

There is remarkably high support for government action on drug costs regardless of the respondents’ political affiliation (see Table 2). 

DB 90 Table 2.png

Comparing 2018 CHESS Survey Results to Other Years

We caution readers against drawing strong conclusions about changes observed between CHES surveys conducted in different years. While the findings between years may be remarkably consistent, small differences in the weighting approach and in the instrument itself (most significantly the addition of the COVID questions in this survey) indicate that direct comparisons should not be made. For more information on the Pennsylvania state surveys, go to Pennsylvania – Healthcare Value Hub.

Funding

This survey was conducted for the Community Voices for Health project, supported by the Robert Wood Johnson Foundation and in collaboration with Public Agenda. For more information on Community Voices for Health, visit www.communityvoicesforhealth.org.

Methodology

Altarum’s Consumer Healthcare Experience State Survey (CHESS) is designed to elicit respondents’ unbiased views on a wide range of health system issues, including confidence using the health system, financial burden and views on fixes that might be needed. 

The survey used a web panel from Dynata with a demographically balanced sample of approximately 1,250 respondents who live in Pennsylvania. The survey was conducted only in English and Spanish and was restricted to adults ages 18 and older. Respondents who finished the survey in less than half the median time were excluded from the final sample, leaving 1,157 cases for analysis. After those exclusions, the demographic composition of respondents was as follows, although not all demographic information has complete response rates:

DB 89 - Demographic Table.png

Altarum in Action

Rhode Island Office of the Health Insurance Commissioner cites CHESS survey in letter to State House Committee on Health and Human Services about HB072 related to reimbursement rates and repealing affordability standards. Read more

Washington State Senator Patty Murray’s office cites the WA CHESS survey in press release about Senate Health, Education, Labor and Pensions (HELP) Committee hearing where Senator Murray questioned CEOs of major pharmaceutical companies about the high prices charged to Americans for their prescription drugs. Read more

Read More Altarum in Action Resources